Xia W, Xu S, Guo Y, Zhao X, Hu H, Zhao Y, Yao Q, Zheng L, Zhang D, Guo C, Fan W, Li H. Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma. Front Oncol 2022;12:1014653. [DOI: 10.3389/fonc.2022.1014653][Reference Citation Analysis]
2
Lee JY, Lee BC, Kim HO, Heo SH, Shin SS, Jeong YY. Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma. Sci Rep 2021;11:24076. [PMID: 34911966 DOI: 10.1038/s41598-021-01839-6][Reference Citation Analysis]
3
Yang XY, Deng JB, An TZ, Zhou S, Li JX. Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization. J Int Med Res 2021;49:3000605211058367. [PMID: 34812068 DOI: 10.1177/03000605211058367][Reference Citation Analysis]